The development and severity of inflammatory bowel diseases and other chronic inflammatory conditions can be influenced by host genetic and environmental factors, including signals derived from commensal bacteria [1] [2] [3] [4] [5] [6] . However, the mechanisms that integrate these diverse cues remain undefined. Here we demonstrate that mice with an intestinal epithelial cell (IEC)-specific deletion of the epigenome-modifying enzyme histone deacetylase 3 (HDAC3 DIEC mice showed significantly increased susceptibility to intestinal damage and inflammation, indicating that epithelial expression of HDAC3 has a central role in maintaining intestinal homeostasis. Re-derivation of HDAC3 DIEC mice into germ-free conditions revealed that dysregulated IEC gene expression, Paneth cell homeostasis and intestinal barrier function were largely restored in the absence of commensal bacteria. Although the specific mechanisms through which IEC-intrinsic HDAC3 expression regulates these complex phenotypes remain to be determined, these data indicate that HDAC3 is a critical factor that integrates commensalbacteria-derived signals to calibrate epithelial cell responses required to establish normal host-commensal relationships and maintain intestinal homeostasis.
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Chronic inflammatory diseases, including asthma, allergy, diabetes and inflammatory bowel diseases, are multifactorial diseases that develop as a result of complex gene-environment interactions [1] [2] [3] [4] [5] [6] . In the case of inflammatory bowel disease, genome-wide association studies have identified more than 160 genes or loci that are associated with disease susceptibility 7 . In addition, signals derived from intestinal commensal microbial communities are not only required for normal intestinal function, but also act as environmental cues that influence inflammatory bowel diseases in genetically susceptible hosts [1] [2] [3] 8, 9 . Intestinal epithelial cells (IECs) function as a crucial cell lineage that integrates microbial signals from the intestinal microenvironment to regulate gene expression and intestinal homeostasis 10, 11 ; however, the mechanisms that coordinate these processes remain undefined. Histone deacetylases (HDACs) are epigenome-modifying enzymes that alter gene expression and can be regulated by endogenous factors, dietary components, synthetic inhibitors, and bacteria-derived signals [12] [13] [14] [15] [16] [17] . The class I histone deacetylase HDAC3 alters transcription through histone deacetylation, and may also mediate the activity of other HDACs, deacetylate non-histone targets, and possess enzyme-independent effects [18] [19] [20] [21] . Tissue-specific deletion of HDAC3 in murine models has suggested critical roles for HDAC3 in complex diseases such as diabetes and heart failure 22, 23 ; however, the functional roles of HDAC3 in regulating intestinal homeostasis in the context of health and disease are unknown.
To characterize HDAC3 expression in the intestinal epithelium, intestinal samples from healthy humans and mice were evaluated. HDAC3 protein was expressed in IECs from human and mouse small and large intestine, and immunohistochemistry revealed nuclear localization of HDAC3 in healthy human colonic IECs (Fig. 1a-c ). IECs were also isolated from inflammatory bowel disease patients with either Crohn's disease, which commonly targets the terminal ileum, or ulcerative colitis, which is restricted to the large intestine. HDAC3 expression was significantly decreased in IECs isolated from the terminal ileum of Crohn's disease patients (Fig. 1d) and the large intestine of ulcerative colitis patients (Fig. 1e ) compared to control patients that had no history of intestinal inflammation, indicating that dysregulated expression of HDAC3 in IECs may be associated with regions of active disease in both forms of inflammatory bowel disease.
To investigate the in vivo functions of IEC-intrinsic HDAC3 expression, IEC-specific HDAC3-deficient (HDAC3 DIEC ) mice were generated. HDAC3 DIEC mice were born at normal Mendelian frequencies, and deletion of HDAC3 was confirmed in IECs (Extended Data Fig. 1a, b) . Genome-wide transcriptional profiling on sort-purified live, EpCAM
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IECs from the large intestine revealed that in vivo deletion of HDAC3 resulted in substantial alterations in IEC-intrinsic gene expression (Extended Data Fig. 1c and Fig. 1f ). Most genes that exhibited dysregulated expression were upregulated compared to floxed HDAC3 (HDAC3 FF ) mice, consistent with a role for HDAC3 in transcriptional repression (Fig. 1f) . DAVID (Database for Annotation, Visualization and Integrated Discovery) and gene-set enrichment analyses revealed several HDAC3-dependent pathways in IECs, including those involved in glutathione metabolism, mitochondria, lipid biosynthesis, PPAR signalling, antigen processing and defence response ( Fig. 1g and Extended Data Fig. 1d ). Altered expression of representative genes in these pathways was confirmed by real-time polymerase chain reaction (PCR) analysis (Fig. 1h) . Collectively, these genome-wide analyses implicate a central role for HDAC3 in coordinating a network of IEC-intrinsic transcriptional pathways that regulate multiple cellular processes.
Analyses of histone acetylation in primary IECs from HDAC3 FF and HDAC3 DIEC mice were conducted using genome-wide chromatin immunoprecipitation-sequencing (ChIP-seq) for H3K9Ac, a histone mark that can be a target for HDAC3 at repressed target genes 24 . ChIP-seq analyses revealed that H3K9Ac levels were significantly increased near genes that were upregulated in IECs isolated from HDAC3 DIEC mice ( Fig. 1i and Extended Data Fig. 1e ). The distribution of H3K9Ac at two representative genes, Scd2 and Gstp1, demonstrated multiple sites of acetylation (Fig. 1j) , and increased levels of H3K9Ac in multiple genes from HDAC3-deficient IECs were confirmed by ChIP-qPCR (Extended Data Fig. 1f) . Collectively, these data indicate that alterations in histone acetylation occur at upregulated genes in IECs deficient in HDAC3. Significant changes in H3K9Ac were not observed near genes for which expression was decreased in IECs from HDAC3 DIEC mice (Fig. 1k) , indicating that these genes are unlikely to be direct targets of HDAC3 enzymatic activity. Further analysis will be required to determine whether HDAC3-dependent histone acetylation, deacetylation of non-histone proteins, or enzyme-independent processes are required for specific transcriptional changes observed in DIEC mice (Fig. 2a) . However, fundamental alterations in Paneth cells were observed in HDAC3 DIEC mice, as indicated by significantly decreased numbers of these cells and reduced lysozyme expression (Fig. 2a-c Data Fig. 2b) , and electron microscopy revealed the presence of degenerating organelle membranes and loss of granules in Paneth cells of adult HDAC3 DIEC mice (Extended Data Fig. 2c ). Although inhibition of Paneth cell differentiation in adult mice may also occur, these data indicate that impaired Paneth cell survival contributes to altered Paneth cell homeostasis in adult HDAC3 DIEC mice. Furthermore, evaluation of the large intestine revealed that HDAC3 DIEC mice exhibited crypt elongation (Fig. 2d, e) and more extensive Ki67 staining within IECs (Extended Data Fig. 2d ), indicating that there is increased IEC proliferation in HDAC3 DIEC mice. Collectively, these findings identify that HDAC3 regulates IEC homeostasis throughout the intestine.
We sought to test whether the alterations in IEC homeostasis observed in HDAC3 DIEC mice were associated with alterations in intestinal barrier function. Naive HDAC3 DIEC mice exhibited increased faecal albumin (Fig. 2f) , increased plasma levels of fluorescein isothiocyanate (FITC) after oral administration of FITC-dextran (Extended Data Fig. 3a) , and increased lipopolysaccharide (LPS) in mesenteric lymph nodes (Fig. 2g) Fig. 3b ) and increased susceptibility to oral Listeria monocytogenes infection (Extended Data Fig. 3c, d ). Furthermore, as HDAC3 DIEC mice matured, they demonstrated an increased prevalence of rectal prolapse ( Fig. 2h and Extended Data Fig. 3e ), and colons from these mice exhibited increased inflammation (Extended Data Fig. 3f, g ) and elevated disease score (Extended Data Fig. 3h ). Collectively, these findings demonstrate that loss of HDAC3 expression in IECs results in impaired barrier function and development of spontaneous intestinal inflammation.
To assess the significance of IEC-intrinsic HDAC3 expression in the context of intestinal damage and inflammation, mice were treated with dextran sodium sulphate (DSS) for 5 days. Whereas HDAC3 FF mice were minimally affected, HDAC3 DIEC mice showed profound weight loss (Fig. 3a) , increased disease severity (Fig. 3b) , colonic shortening (Fig. 3c, d ), increased infiltration of neutrophils and macrophages in the intestine (Fig. 3e) , and extensive intestinal ulceration, loss of crypt architecture, oedema and inflammation (Fig. 3f) , indicating that IECintrinsic HDAC3 expression is critical for limiting DSS-induced intestinal damage and inflammation. In addition to IECs, macrophages provide an important link between the microbiota and intestinal homeostasis 25, 26 .
Notably, unlike HDAC3
DIEC mice, exposure of HDAC3 DLysM mice 24 to DSS did not result in significant weight loss, disease, or intestinal inflammation (Extended Data Fig. 4a-d ), indicating that IEC-intrinsic, but not LysM-expressing myeloid-cell-intrinsic, expression of HDAC3 is critical in maintaining intestinal homeostasis and limiting DSSinduced inflammation.
To test how IEC-intrinsic HDAC3 expression functions in adult mice and to eliminate potential developmental effects of constitutive deletion, we generated an inducible tamoxifen-dependent IEC-specific HDAC3 knockout mouse model (HDAC3 
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Furthermore, increased faecal albumin (Extended Data Fig. 5e ) and FITC-dextran permeability (Extended Data Fig. 5f ) were observed after deletion of HDAC3, demonstrating that IEC-intrinsic expression of HDAC3 dynamically regulates intestinal barrier function in the adult intestine. Tamoxifen-treated HDAC3 DIEC-IND mice subjected to DSS exhibited profound weight loss (Fig. 3g) , increased disease severity (Fig. 3h) , exacerbated colonic shortening (Extended Data Fig. 6a, b) , increased inflammatory cell infiltrates (Extended Data Fig. 6c ), and histological lesions in both the large and small intestine (Extended Data Fig. 6d ). Collectively, these results identify a critical role for HDAC3 in actively regulating IEC function and tissue homeostasis in adult mice.
Dysregulation of intestinal homeostasis and susceptibility to intestinal inflammation are often associated with alterations in commensal bacterial populations [27] [28] [29] [30] . Therefore, pyrosequencing was used to interrogate temporal and spatial differences in microbial diversity within intestinal bacterial communities. Bacterial communities differed significantly between faecal and intestinal samples of HDAC3 FF and HDAC3 DIEC littermate mice, whereas mice within the same genotype had a more similar bacterial composition (Fig. 3i-l and Extended Data Fig. 7a-c) . Most notably, HDAC3 DIEC mice consistently exhibited increased levels of Proteobacteria ( Fig. 3j and Extended Data Fig. 7b, c) . Furthermore, analyses of HDAC3 DIEC-IND mice revealed that alterations in the composition of intestinal bacterial communities occurred after deletion of IEC-intrinsic HDAC3 in adult mice (Extended Data  Fig. 7d, e) . Recent studies have demonstrated that the colitogenic activity of specific microbial communities can result in exacerbated susceptibility to colitis [27] [28] [29] . However, unlike HDAC3 DIEC mice, wild-type mice that were cross-fostered (Fig. 3m ) or co-housed ( Fig. 3n) with HDAC3
DIEC mice did not demonstrate increased susceptibility to DSS (Fig. 3m, n) . Furthermore, germ-free wild-type mice colonized with 
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FF or the HDAC3 DIEC microbiota did not exhibit differences in susceptibility to DSS-induced inflammation (Fig. 3o) or Paneth cell homeostasis (Fig. 3p) .
These results indicate that the intestinal dysbiosis alone is insufficient to cause the dysregulation in IEC homeostasis or susceptibility to intestinal inflammation that occurs in HDAC3 DIEC mice. Therefore, we proposed that HDAC3 expression may be required to integrate signals derived from commensal bacteria to regulate intestinal homeostasis. To test this, HDAC3 DIEC mice were re-derived into germ-free conditions. Genome-wide transcriptional profiling comparing differentially expressed genes of conventionally housed HDAC3 DIEC mice versus germ-free HDAC3 DIEC mice revealed that a significant proportion of HDAC3-dependent gene expression relies on the presence of live commensal bacteria (Fig. 4a) . Furthermore, alterations in most HDAC3-dependent transcriptional pathways, including those involved in antimicrobial defence, occurred only in HDAC3 DIEC mice housed under conventional conditions (Fig. 4b and Extended Data Fig. 8 ), indicating that a dominant role for HDAC3 in regulation of IECintrinsic transcriptional pathways requires commensal-bacteria-derived signals. Consistent with this, whereas faecal albumin levels (Fig. 4c) , Paneth cell homeostasis (Fig. 4d, e) and crypt length (Fig. 4f) were dysregulated in conventionally housed HDAC3
DIEC mice compared to conventionally housed HDAC3 FF mice, these differences were significantly abrogated between germ-free HDAC3
FF versus germ-free HDAC3 DIEC mice (Fig. 4c-f ). In addition, whereas conventionally housed HDAC3 DIEC mice were more susceptible to DSS-induced intestinal inflammation compared to conventionally housed HDAC3 FF mice (Fig. 4g ), minimal differences in intestinal inflammation were observed between germ-free HDAC3 FF versus germ-free HDAC3 DIEC mice (Fig. 4h) .
Collectively, these data indicate that expression of HDAC3 in IECs is critical for the coordinated expression of networks of genes that regulate IEC function and tissue homeostasis in the presence of commensal bacteria. Notably, under germ-free conditions, IEC-intrinsic HDAC3 expression was dispensable for regulation of epithelial barrier integrity and intestinal homeostasis, indicating that HDAC3 integrates commensal-bacteria-derived signals to maintain normal host-commensal relationships (Extended Data Fig. 9 ). Therefore, in addition to established pathways of immune recognition of commensal bacteria via germline encoded pattern recognition receptors, IEC-intrinsic expression of HDAC3 may have an evolutionarily conserved role in regulating hostcommensal bacteria relationships. In this context, IEC-intrinsic HDAC3 may influence susceptibility to multiple systemic chronic inflammatory diseases that are influenced by both host genetic and microbederived factors.
METHODS SUMMARY

HDAC3
DIEC and HDAC3 DIEC-IND mice were generated by breeding HDAC3 FF mice 24 to C57BL/6 mice expressing Cre-recombinase or tamoxifen-dependent Cre recombinase under the control of the villin promoter. Deletion of HDAC3 in HDAC3 DIEC-IND mice was induced by intraperitoneal injection of tamoxifen. Germ-free HDAC3 DIEC mice were re-derived at the University of Pennsylvania Gnotobiotic Mouse Facility. Albumin levels in faecal homogenates were quantified by ELISA. DSS was added to drinking water at 2.5% weight/volume for 5 days. Human intestinal tissue was obtained from the University of Pennsylvania IBD Immunology Initiative. IECs were isolated by shaking intestinal tissue in 1 mM EDTA/1 mM dithiothreitol (DTT) and 5% FCS at 37 uC. For microarray analyses, three biological replicates of EpCAM 1 IECs were sorted for each genotype and condition. ChIP DNA libraries from three biological replicates for each genotype were used for sequencing. DNA from stool and intestinal contents was amplified using barcoded V1-V2 region primers targeting bacterial 16S rRNA gene, sequenced using 454/Roche Titanium technology, analysed using QIIME, and assessed by multiple parameters (Extended Data Fig. 10 ).
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Mice. Previously described HDAC3
FF mice 24 were bred to C57BL/6 mice expressing Cre-recombinase 32 or tamoxifen-dependent Cre recombinase 33 under the control of the villin promoter (Jackson Laboratory) to generate HDAC3 DIEC and HDAC3 DIEC-IND mice, respectively. Genotypes were determined by PCR. Deletion of HDAC3 in HDAC3 DIEC-IND mice was induced by intraperitoneal injection of 1 mg of tamoxifen (Sigma) once per day for 5 days after weaning to adult mice that ranged from 8-10 weeks old. For Paneth cell examination in HDAC3 DIEC-IND mice, tamoxifen was administered for three 5-day intervals during a 30-day period. HDAC3 DLysM mice have been described previously 24 and express Cre recombinase under the control of the lysozyme M promoter. Germ-free HDAC3 DIEC mice were re-derived at the University of Pennsylvania Gnotobiotic Mouse Facility. For cohousing experiments, 4-week-old wild-type and HDAC3
FF or HDAC3 DIEC mice were co-housed for 4 weeks. For cross-fostering experiments, newborn HDAC3 FF mice were transferred to a litter with a HDAC3 DIEC dam and HDAC3 DIEC pups at birth. Colonization of 8-week-old wild-type germ-free mice was performed with caecal contents collected from either HDAC3 FF or HDAC3 DIEC mice. All mice were used at 7-12 weeks old, and age-and gender-matched mice were used for all experiments. Animals were housed up to 5 per cage in a ventilated isolator cage system in a 12 h light/dark cycle, with free access to water and chow. Animals requiring medical attention were provided with appropriate veterinary care by a licensed veterinarian and were excluded from the experiments described. No other exclusion criteria existed. All experiments were done according to the guidelines of the University of Pennsylvania Institutional Animal Care and Use Committee. Germfree mice were maintained in plastic isolator units, were fed autoclaved feed and water and were routinely monitored to ensure the absence of microbial contamination. Human intestinal samples, IEC harvest, RNA, ChIP, real-time PCR and western blotting. De-identified human intestinal tissue from the terminal ileum and rectum were obtained from the University of Pennsylvania IBD Immunology Initiative (IRB 814428). All IBD participants had a confirmed diagnosis of Crohn's disease or ulcerative colitis by a gastroenterologist and had provided informed consent. Patients younger than 18 years of age were excluded. Control samples were obtained from consenting men and women older than 18 years of age with no history of a diagnosis of inflammatory bowel disease, microscopic colitis, or ischaemic colitis. Human IECs were purified from biopsy samples by incubating tissue in 1 mM EDTA/1 mM DTT and 5% FCS at 37 uC for 20-30 min and vortexing every 5 min. Human IECs were 99.3% negative for CD45 1 cells. IECs were isolated from murine samples by shaking intestinal tissue in 1 mM EDTA/1 mM DTT and 5% FCS at 37 uC for 10 min, resulting in 80-90% EpCAM 1 IEC purity. RNA was isolated from cells using the RNeasy kit (Qiagen) then subjected to reverse transcription with Superscript reverse transcriptase (Invitrogen). ChIP was performed as described previously 20, 24 with few modifications. Briefly, cells were fixed in 1% PFA for 10 min and quenched with glycine. Total cell extracts were sonicated using a Bioruptor (Diagenode) and appropriate sonication was confirmed using an Agilent bioanalyzer. Extracts were immunoprecipitated with rabbit anti-H3K9ac (Millipore; 06-942). Real-time PCR was performed using SYBR green chemistry (Applied Biosystems), commercially available primer sets (Qiagen) or custom made primer pairs (Invitrogen). Reactions were run on a real-time PCR system (ABI7500; Applied Biosystems) and data were analysed with a threshold set in the linear range of amplification and processed based on a standard curve of serial tenfold dilutions for each primer set. Samples were normalized to an unaffected endogenous control gene and plotted as mean fold difference (6s.e.m.) relative to control mice. For western blot analysis, IECs were lysed in a modified RIPA buffer and lysates were subjected to immunoblot analysis. Blots were probed with rabbit anti-HDAC3 (Santa Cruz) and mouse anti-actin (Cell Signaling). Flow cytometry. To isolate lamina propria immune cells, IEC and intraepithelial lymphocyte layers were first stripped by shaking sections of large intestine in 5 mM EDTA/1 mM DTT. Remaining tissue was then digested with collagenase (0.5 mg ml , Lin -(CD45, CD4, CD8, CD11b, CD19), EpCAM 1 from large intestinal IEC preparations using a BD Aria II with a 100 mm nozzle. EpCAM staining was performed using APC conjugated anti-EpCAM (eBioscience; G8.8). Three biological replicates were collected for each genotype and condition, each containing 1.0-1.7 3 10 5 cells sorted to a purity of 99%. Total RNA was prepared using TRIzol (Invitrogen) and analysed by the Microarray Core at the University of Pennsylvania. cDNA was amplified using NuGen WT Ovation Pico kit and hybridized to an Affymetrix GeneChip (Mouse Gene 1.0ST). Affymetrix Power Tools software was used for processing and quantile normalization of fluorescence hybridization signals. Transcripts were log 2 -normalized and average values were obtained for analysis of expression. Detailed microarray data have been deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO series accession number GSE50190. Genes with greater than 1.5-fold change were analysed within DAVID (Database for Annotation, Visualization and Integrated Discovery). The R package ComBat was implemented to eliminate non-biological experimental artefacts 34 and the Broad Institute GSEA software was used for gene-set enrichment analysis as described 35 . ChIP-seq. ChIP DNA libraries from three biological replicates for each genotype were prepared for sequencing according to the multiplex amplification protocol from Illumina. Sequencing was performed by the The Functional Genomics Core of the Penn Diabetes Research Center. Sequence reads of 50 base pairs (bp) were obtained using the Solexa Analysis Pipeline. ChIP-seq reads for H3K9ac were mapped to the mouse genome (mm9) using bowtie by allowing up to two mismatches 36 . Reads were normalized to reads per kilobase per 10 million mapped reads and clonal reads were removed. Average H3K9Ac signals for each gene at the TSS 62 kb region were calculated from three independent biological replicates and P values were determined using a paired t-test. ChIP-seq data have been deposited in GEO and are accessible through GEO series accession number GSE50453. Histology, immunohistochemistry and immunofluoresence. Sections of intestine were fixed in 4% paraformaldehyde, paraffin embedded, sectioned and stained with haematoxylin and eosin (H&E), periodic acid-Schiff (PAS)/Alcian blue, anti-HDAC3 (Santa Cruz), anti-Ki67 (AbCam), or anti-caspase 3 (R&D systems) for immunohistochemistry, or anti-lysozyme (Santa Cruz) and DAPI for immunofluoresence. Pathology was scored based on oedema (1-4) and inflammation (1-4). For EM, intestinal tissues were fixed with 2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. After buffer washes, the samples were post-fixed in 2.0% osmium tetroxide for 1 h at room temperature, and rinsed in dH 2 O before en bloc staining with 2% uranyl acetate. After dehydration through a graded ethanol series, the tissue was infiltrated and embedded in EMbed-812 (Electron Microscopy Sciences). Thin sections were stained with uranyl acetate and lead citrate and examined with a JEOL 1010 electron microscope fitted with a Hamamatsu digital camera and AMT Advantage image capture software. In vivo intestinal barrier function assays. Mice were fasted overnight and FITCdextran (0.6 mg g
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; Sigma) diluted in PBS was gavaged the following day. Fluorescence intensity of plasma samples was measured (excitation 485 nm/emission, 535 nm) 4 h after gavage. For faecal albumin assays, faecal pellets were weighed and homogenized in diluent (PBS, 1% BSA, 0.05% Tween 20) . Albumin levels in faecal homogenates were quantified by ELISA according to the manufacturer's protocol (Bethyl Laboratories). LPS levels in mesenteric lymph node homogenates were assayed via the Limulus amebocyte lysate (LAL) test according to the manufacturer's protocol (Lonza). Albumin and LPS levels were normalized to faecal or tissue weight and presented as fold difference relative to HDAC3 FF mice. Murine colitis model. DSS (MP Biomedicals; relative molecular mass 36,000-50,000) was added to drinking water at 2.5% weight/volume for 5 days. Disease was scored as follows: (1) weight loss (no change 5 0; ,5% 5 1; 6-10% 5 2; 11-20% 5 3; . 20% 5 4); (2) faeces (normal 5 0; pasty, semiformed 5 2; liquid, sticky, or unable to defaecate after 5 min 5 4); (3) blood (no blood 5 0; visible blood in rectum 5 1; visible blood on fur 5 2); and (4) general appearance (normal 5 0; piloerection 5 1; lethargy and piloerection 5 2; motionless 5 4). 16S rRNA gene pyrosequencing. Stool and intestinal contents total DNA was extracted using the QIAamp DNA Stool Mini kit (Qiagen). DNA samples were amplified using barcoded V1-V2 region primers targeting bacterial 16S rRNA gene and sequenced using 454/Roche Titanium technology. Sequence analysis was carried out using the QIIME pipeline 37 with default settings and data was submitted to the Sequence Read Archive (SRA) and are accessible through accession number SRP029234. Taxonomic assignments were carried out using RDP. Community structure comparisons were carried out using UniFrac 31, 38 and principal coordinate analysis. For distance analysis in UniFrac, P values were determined using label permutation as implemented in the QIIME package. Pyrosequencing parameters including number of reads, alpha diversity, rarefaction curves, additional PCA plots, and clustering dendrograms are displayed in Extended Data Fig. 10 . Oral L. monocytogenes infection and bactericidal assays. Mice were infected orally with streptomycin-resistant L. monocytogenes with 3 3 10 8 colony forming units (c.f.u.) and weighed daily. Seventy-two hours after infection, mesenteric lymph nodes were homogenized in PBS, and serial dilutions of the homogenates were plated on LB plates containing 100 mg ml 21 streptomycin, incubated at 37 uC RESEARCH LETTER and c.f.u. were counted. For bactericidal assays, small intestinal crypts were isolated, stimulated with 10 mm carbamyl choline (CCh) and assayed against Salmonella enterica serovar Typhimurium as described previously 39 . Statistics. Results are shown as mean 6 s.e.m. To determine group sizes necessary for adequate statistical power, power analysis was performed using preliminary data sets. Mice of the indicated genotypes were assigned at random to groups. Mouse studies were not performed in a blinded fashion. All inclusion/exclusion criteria were pre-established. Statistical significance was determined with the t-test or Mann-Whitney U-test. All data meet the assumptions of the statistical tests used. Within each group there is an estimate of variation, and the variance between groups is similar. For each statistical analysis, appropriate tests were selected based on whether the data was normally distributed and whether multiple comparisons were made. Results were considered significant at *P # 0.05; **P # 0.01. Statistical analyses were performed using Prism version 5.0a (GraphPad Software).
